<DOC>
	<DOCNO>NCT00624780</DOCNO>
	<brief_summary>The purpose study characterize safety efficacy patient generalize anxiety disorder short- ( 3 month ) long-term ( 6 month ) use Pregabalin ( Lyrica ) .</brief_summary>
	<brief_title>Safety Efficacy Evaluation Of Pregabalin ( Lyrica ) With Patients With Generalized Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<criteria>Diagnosis Generalized Anxiety Disorder HAMA score &gt; =18 HAMD ( item 1 ) score &gt; =2 screen baseline Needs pharmacological treatment Current past diagnosis DSM IV Axis I disorder A history fail treatment benzodiazepine Any clinically significant , serious , unstable hematologic , autoimmune , endocrine , cardiovascular , renal , hepatic , gastrointestinal , neurological disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>